Therapeutic Effect of Bee Venom in Holstein Dairy Cows with Clinical Mastitis
10.17555/jvc.2024.41.6.370
- Author:
Seong-Min KIM
1
;
Seon-Jong YUN
;
Dae-Youn HWANG
;
Hyun-Gu KANG
Author Information
1. Laboratory of Veterinary Theriogenology, College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea
- Publication Type:Original Article
- From:
Journal of Veterinary Clinics
2024;41(6):370-376
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study examines the therapeutic effects of bee venom on dairy cows with clinical mastitis, a common and economically significant disease in the dairy industry. While mastitis is traditionally managed with antibiotics, the increasing problem of antibiotic resistance calls for the exploration of alternative treatments. Known for its anti-inflammatory, antimicrobial, and immunomodulatory properties, bee venom was evaluated as a potential alternative. Fifty-one Holstein Friesian cows from five dairy farms, all diagnosed with clinical mastitis, participated in the study. Administered intramammarily for seven consecutive days, the diluted bee venom from New Techniques Laboratory Ltd. was monitored for its effects on clinical symptoms, somatic cell counts, and bacterial cultures at baseline and on days 3, 5, 7, 10, and 14 post-treatment. The results indicate that bee venom is particularly effective against gram-positive bacteria, with notable recovery observed in Staphylococcus saprophyticus infections within 5 days. However, its efficacy against gram-negative bacteria, especially E. coli, was less pronounced, showing improvement in 50% of E. coli cases by day 14. No therapeutic response was noted in cases involving Klebsiella pneumoniae. These findings support the potential of bee venom as an alternative treatment for mastitis, particularly against gram-positive infections but highlight the necessity for further research to improve its effectiveness against gram-negative bacteria and to explore its role in managing antibiotic-resistant strains.
